Cerity Partners LLC Purchases 4,006 Shares of Maximus, Inc. (NYSE:MMS)

Cerity Partners LLC boosted its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 3.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 123,273 shares of the health services provider's stock after acquiring an additional 4,006 shares during the quarter. Cerity Partners LLC owned about 0.22% of Maximus worth $8,406,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of MMS. Raymond James Financial Inc. acquired a new stake in shares of Maximus during the fourth quarter valued at $1,169,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Maximus by 19.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,413 shares of the health services provider's stock worth $1,151,000 after purchasing an additional 2,464 shares during the period. Farther Finance Advisors LLC raised its holdings in shares of Maximus by 109.2% in the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock worth $61,000 after purchasing an additional 428 shares during the period. Avantax Advisory Services Inc. raised its holdings in shares of Maximus by 4.8% during the 4th quarter. Avantax Advisory Services Inc. now owns 19,097 shares of the health services provider's stock valued at $1,426,000 after buying an additional 869 shares during the period. Finally, Cibc World Markets Corp purchased a new stake in shares of Maximus during the 4th quarter valued at about $420,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Maximus Stock Performance

MMS traded down $0.24 during midday trading on Friday, reaching $71.10. The company's stock had a trading volume of 384,473 shares, compared to its average volume of 574,005. The company has a fifty day simple moving average of $71.75 and a 200 day simple moving average of $70.85. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The stock has a market cap of $4.01 billion, a P/E ratio of 14.14 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the company posted $1.57 earnings per share. The firm's quarterly revenue was up 1.0% on a year-over-year basis. Research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.69%. Maximus's dividend payout ratio (DPR) is presently 23.86%.

Insider Buying and Selling at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director owned 14,205 shares of the company's stock, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.